Overview The Cymbalta Pregnancy Registry Status: Recruiting Trial end date: 2021-12-01 Target enrollment: Participant gender: Summary The Cymbalta Pregnancy Registry is a U.S. based Registry designed to monitor women who are exposed to Cymbalta (duloxetine) during pregnancy. This is an observational, exposure-registration and follow-up registry. Details Lead Sponsor: Eli Lilly and CompanyCollaborators: INC ResearchSyneos HealthTreatments: Duloxetine Hydrochloride